Stay updated on MK-3475 and Gemcitabine in NSCLC Clinical Trial
Sign up to get notified when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.

Latest updates to the MK-3475 and Gemcitabine in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded site revision tag v3.5.0 and removed revision tag v3.4.3.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange Detected- The page revision was updated from v3.4.2 to v3.4.3. No visible changes to study details or content are shown.SummaryDifference0.1%

- Check40 days agoChange DetectedTwo new dates were added to the Study Record Dates and two earlier dates were removed.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 and removed an older government funding status notice; these are administrative updates that do not affect the study details or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check61 days agoChange DetectedResults First Posted and Results Posted entries with dates were added, along with a PDF link to the Study Protocol and Statistical Analysis Plan. A government funding status notice was added, and an older 'Frequency of Toxicities' entry was removed.SummaryDifference2%

- Check68 days agoChange DetectedAdded a 'Show glossary' option and updated footer metadata to include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with Revision: v3.4.0. Removed the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.SummaryDifference0.2%

Stay in the know with updates to MK-3475 and Gemcitabine in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.